Cleave Biosciences Headquarters
Looking for information about Cleave Biosciences Headquarters? The links below have collected all the necessary data.
Cleave Biosciences Corporate Headquarters, Office ...
- https://craft.co/cleave-biosciences/locations
- Cleave Biosciences headquarters and office locations Cleave Biosciences is headquartered in Burlingame, CA and has 1 office location across 1 country. View CompanyLocation: 866 Malcolm Rd, Burlingame
Cleave Biosciences Company Profile - Office Locations ...
- https://craft.co/cleave-biosciences
- Cleave Biosciences headquarters is located at 866 Malcolm Rd, Burlingame. Where are Cleave Biosciences offices? Cleave Biosciences has an office in Burlingame. How many offices does Cleave Biosciences have? Cleave Biosciences has 1 office. Learn about Craft real-time company insights.Employees: 9
Cleave Biosciences Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/0283975Z:US
- Cleave Biosciences provides biotechnology services. The Company develops novel protein homeostasis inhibitors for the treatment of cancer. Cleave Biosciences serves patients in …Leader: Scott Harris, Amy Burroughs
Cleave Therapeutics - Crunchbase Company Profile & …
- https://www.crunchbase.com/organization/cleave-biosciences
- Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.Founded: 2010
Cleave Therapeutics – VCP/p97 inhibitors for oncology and ...
- https://cleavetherapeutics.com/
- Newsroom. Contact. VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases. About Us. Our Science. Home admin 2019-08-06T22:22:51-07:00.
About – Cleave Therapeutics
- https://cleavetherapeutics.com/about-2/
- About Cleave Therapeutics Cleave Therapeutics is a clinical stage biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in cellular stress pathways essential to cancer cell growth and survival such as the DNA damage response (DDR) and the response to proteotoxic stress. These pathways are attractive targets for therapeutic use in cancer,
Cleave Therapeutics Company Profile: Valuation & …
- https://pitchbook.com/profiles/company/52961-41
- Apr 09, 2013 · 14-Nov-2011. $44M. $44M. 000.00. Completed. Clinical Trials - Phase 1. To view Cleave Therapeutics’s complete valuation and funding history, request access ».
Team – Cleave Therapeutics
- https://cleavetherapeutics.com/team/
- Amy Burroughs joined Cleave as president and chief executive officer in April 2019, bringing more than 25 years of healthcare and life sciences leadership experience. She began her biotechnology career at Genentech, where she held key roles in commercial strategy and planning across the portfolio, and led the neurology commercial team.
Cleave Therapeutics, Inc. LinkedIn
- https://www.linkedin.com/company/cleavetherapeutics
- Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in ...
Have you found Cleave Biosciences Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.